CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $129,000 | -17.8% | 55,256 | 0.0% | 0.00% | – |
| Q4 2017 | $157,000 | +8.3% | 55,256 | +9.3% | 0.00% | – |
| Q3 2017 | $145,000 | +16.0% | 50,535 | 0.0% | 0.00% | – |
| Q2 2017 | $125,000 | -19.4% | 50,535 | +17.4% | 0.00% | – |
| Q1 2017 | $155,000 | +2.0% | 43,036 | 0.0% | 0.00% | – |
| Q4 2016 | $152,000 | -12.6% | 43,036 | 0.0% | 0.00% | – |
| Q3 2016 | $174,000 | -7.9% | 43,036 | 0.0% | 0.00% | – |
| Q2 2016 | $189,000 | +16.0% | 43,036 | 0.0% | 0.00% | – |
| Q1 2016 | $163,000 | -98.3% | 43,036 | -92.9% | 0.00% | -100.0% |
| Q4 2015 | $9,540,000 | +36.2% | 608,411 | -8.4% | 0.02% | +27.8% |
| Q3 2015 | $7,003,000 | -52.0% | 664,386 | +14.9% | 0.02% | -45.5% |
| Q2 2015 | $14,579,000 | +2.8% | 578,089 | +13.6% | 0.03% | +6.5% |
| Q1 2015 | $14,180,000 | +16.0% | 508,789 | -24.1% | 0.03% | +14.8% |
| Q4 2014 | $12,228,000 | +1850.2% | 670,039 | +1284.7% | 0.03% | +2600.0% |
| Q3 2014 | $627,000 | -20.6% | 48,389 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $790,000 | -7.6% | 48,389 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $855,000 | -27.0% | 48,389 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $1,171,000 | -28.7% | 48,389 | +4.4% | 0.00% | -25.0% |
| Q3 2013 | $1,643,000 | +126.9% | 46,365 | 0.0% | 0.00% | +100.0% |
| Q2 2013 | $724,000 | – | 46,365 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KLP Enterprises, LLC | 6,865,006 | $3,457,000 | 100.00% |
| Meditor Group Ltd | 6,312,700 | $3,179,000 | 0.62% |
| TSP Capital Management Group, LLC | 1,328,207 | $669,000 | 0.34% |
| GREAT POINT PARTNERS LLC | 804,483 | $405,000 | 0.06% |
| Telemetry Investments, L.L.C. | 252,300 | $127,000 | 0.05% |
| Centiva Capital, LP | 187,749 | $95,000 | 0.02% |
| Benchmark Capital Advisors | 54,400 | $27,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 639,800 | $322,000 | 0.02% |
| BOENNING & SCATTERGOOD, INC. | 79,400 | $40,000 | 0.01% |
| LMR Partners LLP | 408,846 | $206,000 | 0.01% |